Do immunoglobulin G and immunoglobulin E anti- l -asparaginase antibodies have distinct implications in children with acute lymphoblastic leukemia? A cross-sectional study

Galindo Rodríguez, Gabriela y Jaime Pérez, José Carlos y Salinas Carmona, Mario César y González Díaz, Sandra Nora y Castro Corona, Ángeles y Cavazos González, Raúl y Treviño Villarreal, Humberto y Heredia Salazar, Alberto Carlos y Gómez Almaguer, David (2017) Do immunoglobulin G and immunoglobulin E anti- l -asparaginase antibodies have distinct implications in children with acute lymphoblastic leukemia? A cross-sectional study. Revista Brasileira de Hematologia e Hemoterapia, 39 (3). pp. 202-209. ISSN 15168484

[img]
Vista previa
Texto
40.pdf - Versión Publicada
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (949kB) | Vista previa

Resumen

Background: l-Asparaginase is essential in the treatment of childhood acute lymphoblastic leukemia. If immunoglobulin G anti-l-asparaginase antibodies develop, they can lead to faster plasma clearance and reduced efficiency as well as to hypersensitivity reactions, in which immunoglobulin E can also participate. This study investigated the presence of immunoglobulin G and immunoglobulin E anti-l-asparaginase antibodies and their clinical associations. Methods: Under 16-year-old patients at diagnosis of B-cell acute lymphoblastic leukemia confirmed by flow cytometry and treated with a uniform l-asparaginase and chemotherapy protocol were studied. Immunoglobulin G anti-l-asparaginase antibodies were measured using an enzyme-linked immunosorbent assay. Intradermal and prick skin testing was performed to establish the presence of specific immunoglobulin E anti-l-asparaginase antibodies in vivo. Statistical analysis was used to investigate associations of these antibodies with relevant clinical events and outcomes. Results: Fifty-one children were studied with 42 (82.35%) having anti-l-asparaginase antibodies. In this group immunoglobulin G antibodies alone were documented in 10 (23.8%) compared to immunoglobulin E alone in 18 (42.8%) patients. Immunoglobulin G together with immunoglobulin E were simultaneously present in 14 patients. Children who produced exclusively immunoglobulin G or no antibodies had a lower event-free survival (p-value = 0.024). Eighteen children (35.3%) relapsed with five of nine of this group who had negative skin tests suffering additional relapses (range: 2–4), compared to none of the nine children who relapsed who had positive skin tests (p-value < 0.001). Conclusion: Children with acute lymphoblastic leukemia and isolated immunoglobulin G anti-l-asparaginase antibodies had a higher relapse rate, whereas no additional relapses developed in children with immunoglobulin E anti-l-asparaginase antibodies after the first relapse.

Tipo de elemento: Article
Palabras claves no controlados: Acute Lymphoblastic leukemia, Allergy, hypersensitivity, L-Asparaginase, Neutralizing antibodies, Silent antibodies
Materias: R Medicina > RC Medicina Interna, Psiquiatría, Neurología
Divisiones: Medicina
Usuario depositante: Editor Repositorio
Creadores:
CreadorEmailORCID
Galindo Rodríguez, GabrielaNO ESPECIFICADONO ESPECIFICADO
Jaime Pérez, José CarlosNO ESPECIFICADONO ESPECIFICADO
Salinas Carmona, Mario CésarNO ESPECIFICADONO ESPECIFICADO
González Díaz, Sandra NoraNO ESPECIFICADOorcid.org/0000-0002-3612-0042
Castro Corona, ÁngelesNO ESPECIFICADONO ESPECIFICADO
Cavazos González, RaúlNO ESPECIFICADONO ESPECIFICADO
Treviño Villarreal, HumbertoNO ESPECIFICADONO ESPECIFICADO
Heredia Salazar, Alberto CarlosNO ESPECIFICADONO ESPECIFICADO
Gómez Almaguer, DavidNO ESPECIFICADONO ESPECIFICADO
Fecha del depósito: 19 Mayo 2020 17:20
Última modificación: 27 Oct 2020 01:20
URI: http://eprints.uanl.mx/id/eprint/14577

Actions (login required)

Ver elemento Ver elemento

Downloads

Downloads per month over past year